|
Vaccine Detail
rVCG- MOMP/HSV-2-gD |
Vaccine Information |
- Vaccine Name: rVCG- MOMP/HSV-2-gD
- Target Pathogen: Chlamydia trachomatis
- Target Disease: Chlamydia
- Vaccine Ontology ID: VO_0004722
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- Vector:
- Preparation: A bivalent combination vaccine formulation comprising rVCG expressing chlamydial MOMP and HSV-2 glycoprotein D (Macmillan et al., 2007).
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Vaccination Protocol: Mice were immunized with the combination vaccine that elicited secretory IgA and IgG2a antibodies to both chlamydial and HSV-2 antigens in serum and vaginal secretions (Macmillan et al., 2007).
- Vaccine Immune Response Type: VO_0003057
- Challenge Protocol: Immunized mice then experienced a genital challenge with high doses of live Chlamydia and HSV-2 (Macmillan et al., 2007).
- Efficacy: Mice immunized with the combination vaccine were prophylactically protected (Macmillan et al., 2007).
|
References |
Macmillan et al., 2007: Macmillan L, Ifere GO, He Q, Igietseme JU, Kellar KL, Okenu DM, Eko FO. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes. FEMS immunology and medical microbiology. 2007; 49(1); 46-55. [PubMed: 17094789].
|
|